[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group].
Nomura Y, Abe O, Enomoto K, Fujiwara K, Tominaga T, Hayashi K, Uchino J, Takahashi M, Hayasaka A, Asaishi K, Okazaki M, Abe R, Kimishima I, Kajiwara T, Haga S, Shimizu T, Miyazaki I, Noguchi M, Yoshida M, Miura S, Taguchi T, Oota J, Sakai K, Kinoshita H, Tashiro H, et al.
Nomura Y, et al. Among authors: abe r, abe o.
Gan To Kagaku Ryoho. 1998 Mar;25(4):553-61.
Gan To Kagaku Ryoho. 1998.
PMID: 9530362
Clinical Trial.
Japanese.